BIOSTATISTICS SHARED RESOURCE ABSTRACT The Biostatistics Shared Resource (BSR) provides comprehensive biostatistics support and collaboration for cancer research projects conducted by Moores Cancer Center (MCC) investigators. Established in 1995, the BSR has been led by Karen Messer since 2006, with additional leadership support from Loki Natarajan, both nationally recognized biostatisticians with distinguished track records in cancer research. The BSR has strong ties to the academic resources of the UCSD Division of Biostatistics. The BSR comprises 8.6 FTE of cancer- funded effort, including 6 faculty and 8 staff biostatisticians at the PhD or Master?s level. In addition, there is a full-time Project Manager, who also coordinates clinical trials support between the BSR, study teams, and the Clinical Trials Office. BSR faculty and staff have offices on the third floor of the MCC building, creating a Biostatistics suite with well-defined signage. Key objectives of the BSR include biostatistics support of new grant applications, and support for design, analysis, interpretation of results and manuscript preparation for cancer-related studies. The BSR also supports 24-CFR-part-11 compliant data capture for investigator-initiated clinical trials using VELOS clinical trials management software, as well as data and safety monitoring, Data and Safety Monitoring Committee (DSMC) reporting, as well as interim and final analyses. The BSR supports statistical review for the Protocol Review and Monitoring Committee (PRMC) and DSMC. BSR services are divided between short-term consulting supported by the CCSG without charge to MCC investigators, and longer-term collaboration that is funded from collaborative grants. Service requests are accepted in person, by phone, email, or web request, and are tracked using a web-based system. Improvements during the reporting period have been recruitment of new participating Biostatistics faculty with addition of specialized expertise in natural language processing and in image analysis, an increase in the total statistical FTE in the BSR, and increased training in Cancer Biostatistics through outreach to MCC members and coordination with the UCSD Biostatistics PhD program. Future plans include moving towards Clinical Data Interchange Standards Consortium (CDISC) compliant data capture, and further diversifying key areas of biostatistics faculty expertise through additional recruitments. During the period 2013-2017, the BSR supported 150 different investigators, co-authored 136 cancer-related, peer-reviewed papers, and assisted with 215 grant submissions. Furthermore, the BSR assisted in developing 73 therapeutic protocols, with 21 currently active and 13 recently completed therapeutic studies. 124 MCC members representing all 5 programs used BSR services, accounting for 89% of shared resource utilization. The BSR received 20% of its funding from the CCSG.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA023100-33
Application #
9703589
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
33
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California, San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Dow, Michelle; Pyke, Rachel M; Tsui, Brian Y et al. (2018) Integrative genomic analysis of mouse and human hepatocellular carcinoma. Proc Natl Acad Sci U S A 115:E9879-E9888
Que, Xuchu; Hung, Ming-Yow; Yeang, Calvin et al. (2018) Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. Nature 558:301-306
Murzin, Vyacheslav L; Woods, Kaley; Moiseenko, Vitali et al. (2018) 4? plan optimization for cortical-sparing brain radiotherapy. Radiother Oncol 127:128-135
Norton, Jeffrey A; Kim, Teresa; Kim, Joseph et al. (2018) SSAT State-of-the-Art Conference: Current Surgical Management of Gastric Tumors. J Gastrointest Surg 22:32-42
Ikeda, Sadakatsu; Tsigelny, Igor F; Skjevik, Åge A et al. (2018) Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma. Oncologist 23:586-593
Buckley, Alexandra R; Ideker, Trey; Carter, Hannah et al. (2018) Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas. Genome Med 10:69
Parish, Austin J; Nguyen, Vi; Goodman, Aaron M et al. (2018) GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers. Cancer 124:4080-4089
Xu, Selene; Thompson, Wesley; Ancoli-Israel, Sonia et al. (2018) Cognition, quality-of-life, and symptom clusters in breast cancer: Using Bayesian networks to elucidate complex relationships. Psychooncology 27:802-809
Tao, Li; Schwab, Richard B; San Miguel, Yazmin et al. (2018) Breast Cancer Mortality in Older and Younger Breast Cancer Patients in California. Cancer Epidemiol Biomarkers Prev :
Sagredo, Eduardo A; Blanco, Alejandro; Sagredo, Alfredo I et al. (2018) ADAR1-mediated RNA-editing of 3'UTRs in breast cancer. Biol Res 51:36

Showing the most recent 10 out of 862 publications